Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Adjuvant/Neoadjuvant

Paolo Ascierto

MD

🏢Istituto Nazionale Tumori IRCCS Fondazione Pascale🌐Italy

Director, Melanoma Unit

82
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Paolo Ascierto is a leading Italian melanoma researcher who has contributed to pivotal trials of BRAF inhibitors and immunotherapy combinations. He has been instrumental in developing adjuvant and neoadjuvant approaches and advancing novel immunotherapy agents including LAG-3 and TIGIT inhibitors. His leadership of the annual Melanoma Bridge meeting fosters global research collaboration.

Share:

🧪Research Fields 研究领域

Melanoma
Immunotherapy combinations
BRAF-targeted therapy
Adjuvant strategies
Novel immunotherapeutics

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Paolo Ascierto 的研究动态

Follow Paolo Ascierto's research updates

留下邮箱,当我们发布与 Paolo Ascierto(Istituto Nazionale Tumori IRCCS Fondazione Pascale)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment